{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:33:12Z","timestamp":1777671192818,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":1152,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacepopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACEP Open"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1002\/emp2.12409","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T12:32:22Z","timestamp":1619699542000},"page":"e12409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Emergency physician perspectives on initiating buprenorphine\/naloxone in the emergency department: A qualitative study"],"prefix":"10.1016","volume":"2","author":[{"given":"Kathryn A.","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine J.","family":"Lavergne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginetta","family":"Salvalaggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savannah M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy Jiaxin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Kestler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Kaczorowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron M.","family":"Orkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlanna","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Hyshka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/emp2.12409_bb0010","unstructured":"Government of Canada. Opioid\u2010related harms in Canada: January 2016 to December 2019. https:\/\/health\u2010infobase.canada.ca\/substance\u2010related\u2010harms\/opioids Accessed September 28, 2020."},{"issue":"11","key":"10.1002\/emp2.12409_bb0015","first-page":"8","article-title":"Drug and opioid\u2010involved overdose deaths \u2013 United States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"Morb Mortal Wkly"},{"issue":"1","key":"10.1002\/emp2.12409_bb0020","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268814000284","article-title":"Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England","volume":"143","author":"Hope","year":"2015","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1002\/emp2.12409_bb0025","doi-asserted-by":"crossref","DOI":"10.1093\/pubmed\/fdh189","article-title":"High rates of primary care and emergency department use among injection drug users in vancouver","volume":"27","author":"Kerr","year":"2005","journal-title":"J Public Health"},{"issue":"6","key":"10.1002\/emp2.12409_bb0030","article-title":"Emergency department\u2010initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention","volume":"32","author":"D'Onofrio","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"26","key":"10.1002\/emp2.12409_bb0035","article-title":"Emergency departments \u2014 a 24\/7\/365 option for combating the opioid crisis","volume":"379","author":"D'Onofrio","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1002\/emp2.12409_bb0040","unstructured":"Canadian Institute for Health Information. Opioid\u2010related harms in Canada. https:\/\/www.cihi.ca\/sites\/default\/files\/document\/opioid\u2010related\u2010harms\u2010report\u20102018\u2010en\u2010web.pdf. Accessed September 28, 2020."},{"key":"10.1002\/emp2.12409_bb0045","unstructured":"Alberta Health. Alberta opioid response surveillance report, Q1 2020. https:\/\/open.alberta.ca\/dataset\/f4b74c38\u201088cb\u201041ed\u2010aa6f\u201032db93c7c391\/resource\/45e03e51\u20100fa8\u201049f8\u201097aa\u201006b527f7f42c\/download\/health\u2010alberta\u2010opioid\u2010response\u2010surveillance\u2010report\u20102020\u2010q1.pdf Accessed October 9, 2020."},{"key":"10.1002\/emp2.12409_bb0050","unstructured":"British Columbia Coroners Service. Illicit drug toxicity deaths January 1, 2010\u2010March 31, 2020. https:\/\/www2.gov.bc.ca\/assets\/gov\/birth\u2010adoption\u2010death\u2010marriage\u2010and\u2010divorce\/deaths\/coroners\u2010service\/statistical\/illicit\u2010drug.pdf Accessed October 9, 2020."},{"issue":"9","key":"10.1002\/emp2.12409_bb0055","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"Can Med Assoc J"},{"issue":"1","key":"10.1002\/emp2.12409_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12875-019-1047-z","article-title":"Attitudes of primary care physicians toward prescribing buprenorphine: a narrative review","volume":"20","author":"Louie","year":"2019","journal-title":"BMC Fam Pract"},{"issue":"16","key":"10.1002\/emp2.12409_bb0065","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department\u2013initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D'Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/emp2.12409_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2018.04.007","article-title":"Identification, management, and transition of care for patients with opioid Use disorder in the emergency department","volume":"72","author":"Duber","year":"2018","journal-title":"Ann Emerg Med"},{"issue":"9","key":"10.1002\/emp2.12409_bb0075","doi-asserted-by":"crossref","first-page":"662","DOI":"10.7326\/0003-4819-148-9-200805060-00006","article-title":"Narrative review: buprenorphine for opioid\u2010dependent patients in office practice","volume":"148","author":"Sullivan","year":"2008","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1002\/emp2.12409_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/add.13900","article-title":"Cost\u2010effectiveness of emergency department\u2010initiated treatment for opioid dependence: treatment for opioid dependence","volume":"112","author":"Busch","year":"2017","journal-title":"Addiction"},{"issue":"11","key":"10.1002\/emp2.12409_bb0085","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/acem.14054","article-title":"Emergency department\u2013initiated interventions for patients with opioid use disorder: a systematic review","volume":"27","author":"Kaczorowski","year":"2020","journal-title":"Acad Emerg Med"},{"key":"10.1002\/emp2.12409_bb0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2016.05.010","article-title":"Primary care physicians\u2019 perspectives on the prescription opioid epidemic","volume":"165","author":"Kennedy\u2010Hendricks","year":"2016","journal-title":"Drug and Alcohol Depend"},{"issue":"2","key":"10.1002\/emp2.12409_bb0095","doi-asserted-by":"crossref","DOI":"10.5811\/westjem.2019.11.44382","article-title":"Emergency department clinicians\u2019 attitudes toward opioid use disorder and emergency department\u2010initiated buprenorphine treatment: a mixed\u2010methods study","volume":"21","author":"Im","year":"2020","journal-title":"West J Emerg Med"},{"issue":"5","key":"10.1002\/emp2.12409_bb0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4561","article-title":"Barriers and facilitators to clinician readiness to provide emergency department\u2010initiated buprenorphine","volume":"3","author":"Hawk","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1002\/emp2.12409_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugpo.2017.11.021","article-title":"A qualitative study comparing physician\u2010reported barriers to treating addiction using buprenorphine and extended\u2010release naltrexone in U.S. office\u2010based practices","volume":"54","author":"Andraka\u2010Christou","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"4","key":"10.1002\/emp2.12409_bb0110","doi-asserted-by":"crossref","DOI":"10.1017\/cem.2020.362","article-title":"Understanding current practice of opioid use disorder management in emergency departments across Canada: a cross\u2010sectional study","volume":"22","author":"Hoyeck","year":"2020","journal-title":"CJEM"},{"key":"10.1002\/emp2.12409_bb0115","unstructured":"Canadian Research Initiative in Substance Misuse. CRISM national guideline for the clinical management of opioid use disorder. https:\/\/crism.ca\/wp\u2010content\/uploads\/2018\/03\/CRISM_NationalGuideline_OUD\u2010ENG.pdf. Accessed February 4, 2021."},{"issue":"4","key":"10.1002\/emp2.12409_bb0120","article-title":"Opioid substitution therapy \u2010 A study of GP participation in prescribing","volume":"40","author":"Scarborough","year":"2011","journal-title":"Aust Fam Physician"},{"issue":"3","key":"10.1002\/emp2.12409_bb0125","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/02791072.2019.1566583","article-title":"Barriers to buprenorphine expansion in ohio: a time\u2010elapsed qualitative study","volume":"51","author":"Molfenter","year":"2019","journal-title":"J Psychoactive Drugs"},{"issue":"1","key":"10.1002\/emp2.12409_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-017-0422-5","article-title":"Conducting a team\u2010based multi\u2010sited focused ethnography in primary care","volume":"17","author":"Bikker","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1002\/emp2.12409_bb0135","first-page":"1","article-title":"Guidance on performing focused ethnographies with an emphasis on healthcare research","volume":"18","author":"Higginbottom","year":"2013","journal-title":"Qual Rep"},{"key":"10.1002\/emp2.12409_bb0140","series-title":"Essentials of Qualitative Inquiry","author":"Mayan","year":"2009"},{"issue":"1","key":"10.1002\/emp2.12409_bb0145","doi-asserted-by":"crossref","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?: an experiment with data saturation and variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"key":"10.1002\/emp2.12409_bb0150","unstructured":"NVivo qualitative data analysis software; QSR International Pty Ltd. Version 12, 2018."},{"issue":"1","key":"10.1002\/emp2.12409_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2648.2007.04569.x","article-title":"The qualitative content analysis process","volume":"62","author":"Elo","year":"2008","journal-title":"J Adv Nurs"},{"key":"10.1002\/emp2.12409_bb0160","series-title":"Rigor in Qualitative Research. In: The SAGE Encyclopedia of Qualitative Research Methods","author":"Given","year":"2008"},{"issue":"1","key":"10.1002\/emp2.12409_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14659891.2018.1510051","article-title":"The role of medical students\u2019 training and community placement as a tool to enhance medical education in Canada","volume":"24","author":"Jozaghi","year":"2019","journal-title":"J Subst Use"},{"key":"10.1002\/emp2.12409_bb0170","unstructured":"Verma S. Report on the AFMC response to the Canadian opioid crisis. https:\/\/www.schulich.uwo.ca\/continuingprofessionaldevelopment\/docs\/Health\u2010Canada\u2010Opioid\u2010Final\u2010Report\u2010AFMC\u2010Nov\u20102017.pdf. Accessed September 25, 2020."},{"key":"10.1002\/emp2.12409_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","article-title":"Why aren't physicians prescribing more buprenorphine?","volume":"78","author":"Huhn","year":"2017","journal-title":"J Subst Use Treat"},{"key":"10.1002\/emp2.12409_bb0180","first-page":"3019","article-title":"Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians","volume":"15","author":"DeFlavio","year":"2015","journal-title":"Rural Remote Health"},{"issue":"2","key":"10.1002\/emp2.12409_bb0185","doi-asserted-by":"crossref","DOI":"10.3109\/13814788.2015.1120286","article-title":"How to overcome hurdles in opiate substitution treatment? A qualitative study with general practitioners in Belgium","volume":"22","author":"Fraeyman","year":"2016","journal-title":"Eur J Gen Pract"},{"issue":"4","key":"10.1002\/emp2.12409_bb0190","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/cem.2019.24","article-title":"Buprenorphine\/naloxone induction in a Canadian emergency department with rapid access to community\u2010based addictions providers","volume":"21","author":"Hu","year":"2019","journal-title":"CJEM"}],"container-title":["JACEP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/emp2.12409","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/emp2.12409","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2688115224011184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2688115224011184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/emp2.12409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T02:03:19Z","timestamp":1737770599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2688115224011184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2688115224011184"],"URL":"https:\/\/doi.org\/10.1002\/emp2.12409","relation":{},"ISSN":["2688-1152"],"issn-type":[{"value":"2688-1152","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency physician perspectives on initiating buprenorphine\/naloxone in the emergency department: A qualitative study","name":"articletitle","label":"Article Title"},{"value":"JACEP Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/emp2.12409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 THE AUTHORS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"e12409"}}